BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $5.79 million. The enterprise value is $1.30 million.
Important Dates
The next estimated earnings date is Thursday, March 26, 2026, after market close.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 21.44 million shares outstanding. The number of shares has increased by 24.38% in one year.
| Current Share Class | 21.44M |
| Shares Outstanding | 21.44M |
| Shares Change (YoY) | +24.38% |
| Shares Change (QoQ) | +4.30% |
| Owned by Insiders (%) | 7.04% |
| Owned by Institutions (%) | 9.99% |
| Float | 5.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.10 |
| Forward PS | 2.87 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 3.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37
| Current Ratio | 1.37 |
| Quick Ratio | 1.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -207.73% and return on invested capital (ROIC) is -148.19%.
| Return on Equity (ROE) | -207.73% |
| Return on Assets (ROA) | -89.73% |
| Return on Invested Capital (ROIC) | -148.19% |
| Return on Capital Employed (ROCE) | -657.55% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | $34,855 |
| Profits Per Employee | -$1.15M |
| Employee Count | 11 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.21% in the last 52 weeks. The beta is 0.24, so BRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -88.21% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.43 |
| Relative Strength Index (RSI) | 13.97 |
| Average Volume (20 Days) | 3,835,680 |
Short Selling Information
The latest short interest is 132,462, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 132,462 |
| Short Previous Month | 132,508 |
| Short % of Shares Out | 0.62% |
| Short % of Float | 2.21% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
In the last 12 months, BRTX had revenue of $383,400 and -$12.67 million in losses. Loss per share was -$1.48.
| Revenue | 383,400 |
| Gross Profit | 357,853 |
| Operating Income | -14.51M |
| Pretax Income | -12.67M |
| Net Income | -12.67M |
| EBITDA | -14.30M |
| EBIT | -14.51M |
| Loss Per Share | -$1.48 |
Full Income StatementBalance Sheet
The company has $4.49 million in cash and n/a in debt, with a net cash position of $4.49 million or $0.21 per share.
| Cash & Cash Equivalents | 4.49M |
| Total Debt | n/a |
| Net Cash | 4.49M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 2.21M |
| Book Value Per Share | 0.27 |
| Working Capital | 1.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.72 million and capital expenditures -$48,834, giving a free cash flow of -$10.77 million.
| Operating Cash Flow | -10.72M |
| Capital Expenditures | -48,834 |
| Free Cash Flow | -10.77M |
| FCF Per Share | -$0.50 |
Full Cash Flow StatementMargins
| Gross Margin | 93.34% |
| Operating Margin | -3,785.07% |
| Pretax Margin | -3,304.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.38% |
| Shareholder Yield | -24.38% |
| Earnings Yield | -218.91% |
| FCF Yield | -186.08% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 208.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4,000 |
Scores
BRTX has an Altman Z-Score of -47.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -47.37 |
| Piotroski F-Score | 2 |
